← back to search

Craig Innes

Aurum Institute ·
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS Research and Interventions, Vaccine Coverage and Hesitancy, and SARS-CoV-2 and COVID-19 Research.
h-index
23
citations
1,740
works
51
NIH funding
primary concept
Medicine
email

Recent publications

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
The Lancet Infectious Diseases 2025cited by 25position: middledoi
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk
The Journal of Infectious Diseases 2022cited by 50position: middledoi
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
New England Journal of Medicine 2021cited by 230position: middledoi
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
The Lancet Infectious Diseases 2021cited by 153position: middledoi
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
The Lancet Global Health 2021cited by 50position: middledoi
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
PLoS ONE 2015cited by 35position: middledoi
A novel HIV treatment model using private practitioners in South Africa
Sexually Transmitted Infections 2012cited by 17position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Gavin Churchyard · Médecins Sans Frontières2 papers (2012–2015)Salome Charalambous · London School of Hygiene & Tropical Medicine1 papers (2012–2012)Linda‐Gail Bekker · Desmond Tutu HIV Foundation1 papers (2015–2015) · 1 papers (2012–2012)Carter Bentley · Jisc1 papers (2015–2015)Christopher J. Hoffmann · Johns Hopkins University1 papers (2012–2012)Fatima Laher · National Health Laboratory Service1 papers (2015–2015) · 1 papers (2015–2015)Lawrence Corey · Infectious Disease Research Institute1 papers (2015–2015) · 1 papers (2015–2015)Alison D. Grant · London School of Hygiene & Tropical Medicine1 papers (2012–2012)Michael Robertson · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2015–2015)Surita Roux · University of Cape Town1 papers (2015–2015)Peter B. Gilbert · Fred Hutch Cancer Center1 papers (2015–2015) · 1 papers (2012–2012) · 1 papers (2015–2015) · 1 papers (2015–2015)Zoe Moodie · Fred Hutch Cancer Center1 papers (2015–2015)Glenda Gray · South African Medical Research Council1 papers (2015–2015)Mary Allen · University of Colorado Boulder1 papers (2015–2015)